+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-08-07Number of Pages: 189

Assisted Reproductive Technology Market (Technology - In Vitro Fertilization, Artificial Insemination, Surrogacy; Procedures - Frozen Donor, Frozen Non Donor, Fresh Donor, Fresh Non Donor, Embryo Banking; End User - Fertility Clinics, Hospitals) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Assisted Reproductive Technology Market: Snapshot

The assisted reproductive technology market comprises various medical procedures used to help conception and reduce the chances of abnormalities in the ensuing pregnancy. The market has picked up steam in recent years due to the rising prevalence of infertility and related conditions and the rising disposable income of consumers, which is allowing an increasing number to obtain medical solutions. The increasing social acceptance of assisted reproductive technology has also aided the global market for the same, which is likely to exhibit rapid progress in the coming years.

global assisted reproductive technology market

In Vitro Fertilization Likely to Lead Assisted Reproductive Technology Market

By technology, the global assisted reproductive technology market is segmented into in vitro fertilization, surrogacy, artificial insemination, and others. In vitro fertilization accounted for more than 62% of the global assisted reproductive technology market in 2016 and is likely to retain a dominant share in the coming years thanks to the rising number of citizens who are aware of the ease and efficacy of in vitro fertilization procedures. In vitro fertilization is further segmented into intra-cytoplasmic sperm injection (ICSI), and preimplantation genetic diagnosis (PGD). Preimplantation genetic diagnosis is likely to play an important role in the growth of the global assisted reproductive technology market in the coming years, due to the rising amount of information available on the risk of congenital genetic disorders and their treatment.

Based on procedure, the assisted reproductive technology market is segmented into frozen donor, frozen non donor, fresh donor, fresh non donor, and embryo banking. Of these, the fresh non donor segment is likely to dominate the global assisted reproductive technology market in the coming years. The segment held a majority share of 51.8% in the global assisted reproductive technology market in 2016. It benefits primarily from the desire of most parents to have children with their own genetic makeup rather than having another person involved at any stage.

Geographically, the global assisted reproductive technology market is led by Europe. The market accounted for 35% of the global assisted reproductive technology market in 2016 and is likely to remain the outright leader in the coming years despite growing demand from Asia Pacific. North America is also likely to remain a key contributor to the global assisted reproductive technology market in the coming years due to the growing prevalence of reproductive conditions in the region.

Rising Demand for Fertility Clinics Aids Growth of Assisted Reproductive Technology Market

One of the key drivers for the global assisted reproductive technology market is the rising number of fertility clinics in developing regions and the gradual lifting of the social taboos around the topic. Though developed countries remain by far the leading contributors to the global assisted reproductive technology market, developing regions such as Asia Pacific are likely to emerge as key markets for assisted reproductive technology in the coming years.

The assisted reproductive technology market has also been boosted by the rising demand from same-sex couples. The growing demand for legalization of same-sex relationships in various regions is thus likely to be a crucial driver for the global assisted reproductive technology market in the coming years.

Key players in the global assisted reproductive technology market include Merck, CooperSurgical, Inc., Irvine Scientific, Vitrolife AB, Hamilton Thorne, Inc., Nidacon International AB, Laboratoire CCD, Planer PLC, Esco Micro Pte. Ltd. (Esco Group), and Nikon Corporation. Merck holds a dominant share in the global assisted reproductive technology market due to its widespread portfolio.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Assisted Reproductive Technology Market 

4. Market Overview
     4.1. Introduction
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
4.5. Global Assisted Reproductive Technology MarketAnalysis and Forecasts, 2015–2025
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Assisted Reproductive Technology Market- Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Market Outlook
     4.9. Assisted Reproductive Technology: Regional Funding Scenario
     4.10. In Vitro Fertilization Costs, by Region, 2016
     4.11. Assisted Reproductive Technology: Indication

5. Global Assisted Reproductive Technology MarketAnalysis and Forecasts, By Technology
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Technology , 2015–2025
            5.4.1. In Vitro Fertilization
                     5.4.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     5.4.1.2 .Preimplantation Genetic Diagnosis (PGD)
            5.4.2. Artificial Insemination
                     5.4.2.1. Intrauterine Insemination (IUI)
                     5.4.2.2. Intracervical Insemination (ICI)
                     5.4.2.3. Others
            5.4.3. Surrogacy
            5.4.4. Others
     5.5. Market Attractiveness By Technology

6. Global Assisted Reproductive Technology MarketAnalysis and Forecasts, By Procedure 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By Procedure , 2015–2025
            6.4.1. Frozen Donor
            6.4.2. Frozen Non Donor
            6.4.3. Fresh Donor
            6.4.4. Fresh Non Donor
            6.4.5. Embryo Banking
6.5. Market Attractiveness By Procedure 

7. Global Assisted Reproductive Technology MarketAnalysis and Forecasts, By End User 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast By End User , 2015–2025
            7.4.1. Fertility Clinics 
            7.4.2. Hospitals
            7.4.3. Others
     7.5. Market Attractiveness By End User 

8. Global Assisted Reproductive Technology MarketAnalysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Value Forecast By Region
            8.3.1. North America 
            8.3.2. Europe 
            8.3.3. Asia Pacific 
            8.3.4. Latin America 
            8.3.5. Middle East and Africa 
     8.4. Market Attractiveness By Country/Region

9. North America Assisted Reproductive Technology MarketAnalysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Policies and Regulations
            9.1.3. Key Trends
     9.2. Market Value Forecast By Technology , 2015–2025
            9.2.1. In Vitro Fertilization
                     9.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     9.2.1.2. Preimplantation Genetic Diagnosis (PGD)
            9.2.2. Artificial Insemination
                     9.2.2.1. Intrauterine Insemination (IUI)
                     9.2.2.2. Intracervical Insemination (ICI)
                     9.2.2.3. Others
            9.2.3. Surrogacy
            9.2.4. Others
     9.3. Market Value Forecast By Procedure , 2015–2025
            9.3.1. Frozen Donor
            9.3.2. Frozen Non Donor
            9.3.3. Fresh Donor
            9.3.4. Fresh Non Donor
            9.3.5. Embryo Banking
     9.4. Market Value Forecast By End User , 2015–2025
            9.4.1. Fertility Clinics 
            9.4.2. Hospitals
            9.4.3. Others
     9.5. Market Value Forecast By Country , 2015–2025
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Technology
            9.6.2. By Procedure 
            9.6.3. By End User 
            9.6.4. By Country

10. Europe Assisted Reproductive Technology MarketAnalysis and Forecast
     10.1.Introduction
            10.1.1. Key Findings
            10.1.2. Policies and Regulations
            10.1.3. Key Trends
     10.2.Market Value Forecast By Technology , 2015–2025
            10.2.1. In Vitro Fertilization
                     10.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     10.2.1.2. Preimplantation Genetic Diagnosis (PGD)
            10.2.2. Artificial Insemination
                     10.2.2.1. Intrauterine Insemination (IUI)
                     10.2.2.2. Intracervical Insemination (ICI)
                     10.2.2.3. Others
            10.2.3. Surrogacy
            10.2.4. Others
     10.3.Market Value Forecast By Procedure , 2015–2025
            10.3.1. Frozen Donor
            10.3.2. Frozen Non Donor
            10.3.3. Fresh Donor
            10.3.4. Fresh Non Donor
            10.3.5. Embryo Banking
     10.4.Market Value Forecast By End User , 2015–2025
            10.4.1. Fertility Clinics 
            10.4.2. Hospitals
            10.4.3. Others
     10.5.Market Value Forecast By Country , 2015–2025
            10.5.1. Germany
            10.5.2. France
            10.5.3. U.K.
            10.5.4. Spain
            10.5.5. Italy
            10.5.6. Russia
            10.5.7. Rest of Europe
     10.6.Market Attractiveness Analysis 
            10.6.1. By Technology
            10.6.2. By Procedure 
            10.6.3. By End User 
            10.6.4. By Country

11. Asia Pacific Assisted Reproductive Technology MarketAnalysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
            11.1.2. Policies and Regulations
            11.1.3. Key Trends
     11.2.Market Value Forecast By Technology, 2015–2025
            11.2.1. In Vitro Fertilization
                     11.2.1.1.Intra-cytoplasmic Sperm Injection (ICSI) 
                     11.2.1.2.Preimplantation Genetic Diagnosis (PGD)
            11.2.2. Artificial Insemination
                     11.2.2.1.Intrauterine Insemination (IUI)
                     11.2.2.2.Intracervical Insemination (ICI)
                     11.2.2.3.Others
            11.2.3. Surrogacy
            11.2.4. Others
     11.3.Market Value Forecast By Procedure, 2015–2025
            11.3.1. Frozen Donor
            11.3.2. Frozen Non Donor
            11.3.3. Fresh Donor
            11.3.4. Fresh Non Donor
            11.3.5. Embryo Banking
     11.4.Market Value Forecast By End User, 2015–2025
            11.4.1. Fertility Clinics 
            11.4.2. Hospitals
            11.4.3. Others
     11.5.Market Value Forecast By Country, 2015–2025
            11.5.1. China
            11.5.2. Japan
            11.5.3. India
            11.5.4. Australia & New Zealand
            11.5.5. Rest of Asia Pacific
     11.6.Market Attractiveness Analysis 
            11.6.1. By Technology
            11.6.2. By Procedure 
            11.6.3. By End User 
            11.6.4. By Country

12. Latin America Assisted Reproductive Technology MarketAnalysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
            12.1.2. Policies and Regulations
            12.1.3. Key Trends
     12.2.Market Value Forecast By Technology , 2015–2025
            12.2.1. In Vitro Fertilization
                     12.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     12.2.1.2. Preimplantation Genetic Diagnosis (PGD)
            12.2.2. Artificial Insemination
                     12.2.2.1. Intrauterine Insemination (IUI)
                     12.2.2.2. Intracervical Insemination (ICI)
                     12.2.2.3. Others
            12.2.3. Surrogacy
            12.2.4. Others
     12.3.Market Value Forecast By Procedure , 2015–2025
            12.3.1. Frozen Donor
            12.3.2. Frozen Non Donor
            12.3.3. Fresh Donor
            12.3.4. Fresh Non Donor
            12.3.5. Embryo Banking
     12.4.Market Value Forecast By End User , 2015–2025
            12.4.1. Fertility Clinics 
            12.4.2. Hospitals
            12.4.3. Others
     12.5.Market Value Forecast By Country , 2015–2025
            12.5.1. Brazil
            12.5.2. Mexico
            12.5.3. Rest of Latin America
     12.6.Market Attractiveness Analysis 
            12.6.1. By Technology
            12.6.2. By Procedure 
            12.6.3. By End User 
            12.6.4. By Country

13. Middle East and Africa Assisted Reproductive Technology MarketAnalysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
            13.1.2. Policies and Regulations
            13.1.3. Key Trends
     13.2.Market Value Forecast By Technology , 2015–2025
            13.2.1. In Vitro Fertilization
                     13.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     13.2.1.2. Preimplantation Genetic Diagnosis (PGD)
            13.2.2. Artificial Insemination
                     13.2.2.1. Intrauterine Insemination (IUI)
                     13.2.2.2. Intracervical Insemination (ICI)
                     13.2.2.3. Others
            13.2.3. Surrogacy
            13.2.4. Others
     13.3.Market Value Forecast By Procedure , 2015–2025
            13.3.1. Frozen Donor
            13.3.2. Frozen Non Donor
            13.3.3. Fresh Donor
            13.3.4. Fresh Non Donor
            13.3.5. Embryo Banking
     13.4.Market Value Forecast By End User , 2015–2025
            13.4.1. Fertility Clinics 
            13.4.2. Hospitals
            13.4.3. Others
     13.5.Market Value Forecast By Country , 2015–2025
            13.5.1. GCC Countries
            13.5.2. South Africa
            13.5.3. Rest of Middle East and Africa
     13.6.Market Attractiveness Analysis 
            13.6.1. By Technology
            13.6.2. By Procedure 
            13.6.3. By End User 
            13.6.4. By Country

14. Competition Landscape
     14.1.Market Player – Competition Matrix (By Tier and Size of companies)
     14.2.Market Share Analysis By Company (2016)
     14.3. ART Service Providers: Market Snapshot
     14.4.Company Profiles 
            14.4.1. Merck KGaA
                     14.4.1.1 Overview
                     14.4.1.2 Financials
                     14.4.1.3.Recent Developments
                     14.4.1.4 Strategy
            14.4.2. CooperSurgical, Inc.
                     14.4.2.1 Overview
                     14.4.2.2 Financials
                     14.4.2.3.Recent Developments
                     14.4.2.4. Strategy
                     14.4.3. Irvine Scientific.
                     14.4.3.1 Overview
                     14.4.3.2 Financials
                     14.4.3.3.Recent Developments
                     14.4.3.4. Strategy
            14.4.4. Vitrolife AB.
                     14.4.4.1 Overview
                     14.4.4.2 Financials
                     14.4.4.3.Recent Developments
                     14.4.4.4. Strategy
            14.4.5. Hamilton Thorne, Inc.
                     14.4.5.1 Overview
                     14.4.5.2 Financials
                     14.4.5.3.Recent Developments
                     14.4.5.4. Strategy
            14.4.6. Nikon Corporation 
                     14.4.6.1 Overview
                     14.4.6.2 Financials
                     14.4.6.3.Recent Developments
                     14.4.6.4. Strategy
            14.4.7 Nidacon International AB 
                     14.4.7.1 Overview
                     14.4.7.2 Financials
                     14.4.7.3.Recent Developments
                     14.4.7.4. Strategy
            14.4.8. Laboratoire CCD 
                     14.4.8.1 Overview
                     14.4.8.2 Financials
                     14.4.8.3.Recent Developments
                     14.4.8.4. Strategy
            14.4.9. Planer PLC 
                     14.4.9.1 Overview
                     14.4.9.2 Financials
                     14.4.9.3.Recent Developments
                     14.4.9.4. Strategy
            14.4.10. Esco Micro Pte. Ltd. (Esco Group)
                     14.4.10.1 Overview
                     14.4.10.2 Financials
                     14.4.10.3.Recent Developments
                     14.4.10.4. Strategy

List of Figures

Figure 01: Global Assisted Reproductive Technology, Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Global Assisted Reproductive Technology Market Value Share, by Technology (2016)
Figure 03: Global Assisted Reproductive Technology Market Value Share, by Procedures (2016)
Figure 04: Global Assisted Reproductive Technology Market Value Share, by End User (2016)
Figure 05: Global Assisted Reproductive Technology Market Value Share, by Region (2016)
Figure 06: Global Assisted Reproductive Technology Market Value Share, by Technology, 2017 and 2025
Figure 07: Global Assisted Reproductive Technology Market Attractiveness, by Technology, 2017–2025
Figure 08: Global In Vitro Fertilization in Assisted Reproductive Technology, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 09: Global Artificial Insemination in Assisted Reproductive Technology, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: Global Surrogacy in Assisted Reproductive Technology, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 11: Global others technology in Assisted Reproductive Technology, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: Global Assisted Reproductive Technology Market Value Share, by Procedure 2017 and 2025
Figure 13: Global Assisted Reproductive Technology Market Attractiveness, by Procedure, 2017–2025
Figure 14: Global Assisted Reproductive Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Frozen Donor, 2015–2025
Figure 15: Global Assisted Reproductive Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Frozen Non Donor, 2015–2025
Figure 16: Global Assisted Reproductive Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fresh Donor, 2015–2025
Figure 17: Global Assisted Reproductive Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%), Fresh Non Donor, 2015–2025
Figure 18: Global Assisted Reproductive Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Embryo Banking, 2015–2025
Figure 19: Global Assisted Reproductive Technology Market Value Share, by End-user, 2017 and 2025
Figure 20: Global Assisted Reproductive Technology Market Attractiveness, by End-user, 2017–2025
Figure 21: Global Assisted Reproductive Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fertility Clinics, 2015–2025
Figure 22: Global Assisted Reproductive Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
Figure 23: Global Assisted Reproductive Technology, Market Revenue (US$ Mn) and Y-o-Y Growth (%), Other End-users, 2015–2025
Figure 24: Global Assisted Reproductive Technology Market Value Share, by Region, 2017 and 2025 
Figure 25: Global Assisted Reproductive Technology Market Attractiveness, by Region, 2017–2025
Figure 26: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 27: North America Assisted Reproductive Technology Market Attractiveness, by Country, 2017–2025
Figure 28: North America Assisted Reproductive Technology Market Value Share, by Country, 2017 and 2025
Figure 29: North America Assisted Reproductive Technology Market Value Share, by Technology, 2017 and 2025
Figure 30: North America Assisted Reproductive Technology Market Attractiveness, by Technology, 2017–2025
Figure 31: North America Assisted Reproductive Technology Market Value Share, by Procedure, 2017 and 2025
Figure 32: North America Assisted Reproductive Technology Market Attractiveness, by Procedure, 2017–2025
Figure 33: North America Assisted Reproductive Technology Market Value Share, by End-user, 2017 and 2025
Figure 34: North America Assisted Reproductive Technology Market Attractiveness, by End-user, 2017–2025
Figure 35: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 36: Europe Assisted Reproductive Technology Market Attractiveness, by Country, 2017–2025
Figure 37: Europe Assisted Reproductive Technology Market Value Share, by Country, 2017 and 2025
Figure 38: Europe Assisted Reproductive Technology Market Value Share, by Technology, 2017 and 2025
Figure 39: Europe Assisted Reproductive Technology Market Attractiveness, by Technology, 2017–2025
Figure 40: Europe Assisted Reproductive Technology Market Value Share, by Procedure, 2017 and 2025
Figure 41: Europe Assisted Reproductive Technology Market Attractiveness, by Procedure, 2017–2025
Figure 42: Europe Assisted Reproductive Technology Market Value Share, by End-user, 2017 and 2025
Figure 43: Europe Assisted Reproductive Technology Market Attractiveness, by End-user, 2017–2025
Figure 44: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 45: Asia Pacific Assisted Reproductive Technology Market Value Share, by Country, 2017 and 2025
Figure 46: Asia Pacific Assisted Reproductive Technology Market Attractiveness, by Country, 2017–2025
Figure 47: Asia Pacific Assisted Reproductive Technology Market Value Share, by Technology, 2017 and 2025
Figure 48: Asia Pacific Assisted Reproductive Technology Market Attractiveness, by Technology, 2017–2025
Figure 49: Asia Pacific Assisted Reproductive Technology Market Value Share, by Procedures, 2017 and 2025
Figure 50: Asia Pacific Assisted Reproductive Technology Market Attractiveness, by Procedures, 2017–2025
Figure 51: Asia Pacific Assisted Reproductive Technology Market Value Share, by End User, 2017 and 2025
Figure 52: Asia Pacific Assisted Reproductive Technology Market Attractiveness, by End User, 2017–2025
Figure 53: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 54: Latin America Assisted Reproductive Technology Market Value Share, by Country, 2017 and 2025
Figure 55: Latin America Assisted Reproductive Technology Market Attractiveness, by Country, 2017–2025
Figure 56: Latin America Assisted Reproductive Technology Market Value Share, by Technology, 2017 and 2025
Figure 57: Latin America Assisted Reproductive Technology Market Attractiveness, by Technology, 2017–2025
Figure 58: Latin America Assisted Reproductive Technology Market Value Share, by Procedures, 2017 and 2025
Figure 59: Latin America Assisted Reproductive Technology Market Attractiveness, by Procedures, 2017–2025
Figure 60: Latin America Assisted Reproductive Technology Market Value Share, by End User, 2017 and 2025
Figure 61: Latin America Assisted Reproductive Technology Market Attractiveness, by End User, 2017–2025
Figure 62: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 63: Middle East & Africa Assisted Reproductive Technology Market Value Share, by Country, 2017 and 2025
Figure 64: Middle East & Africa Assisted Reproductive Technology Market Attractiveness, by Country, 2017–2025
Figure 65: Middle East & Africa   Assisted Reproductive Technology Market Value Share, by Technology, 2017 and 2025
Figure 66: Middle East & Africa Assisted Reproductive Technology Market Attractiveness, by Technology, 2017–2025
Figure 67: Middle East & Africa Assisted Reproductive Technology Market Value Share, by Procedures, 2017 and 2025
Figure 68: Middle East & Africa   Assisted Reproductive Technology Market Attractiveness, by Procedures, 2017–2025
Figure 69: Middle East & Africa   Assisted Reproductive Technology Market Value Share, by End User, 2017 and 2025
Figure 70: Middle East & Africa   Assisted Reproductive Technology Market Attractiveness, by End User, 2017–2025
Figure 71: Global Assisted Reproductive Technology Market Share Analysis, by Company, 2016

 

List of Tables

Table 01: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 02: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by In Vitro Fertilization, 2015–2025
Table 03: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Artificial Insemination, 2015–2025
Table 04: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 05: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End User, 2015–2025
Table 06: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 07: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 08: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 09: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – In Vitro Fertilization, 2015–2025
Table 10: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – Artificial Insemination, 2015–2025
Table 11: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure 2015–2025
Table 12: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 13: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 15: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – In Vitro Fertilization, 2015–2025
Table 16: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – Artificial Insemination, 2015–2025
Table 17: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure 2015–2025
Table 18: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 19: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 20: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 21: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – In Vitro Fertilization, 2015–2025
Table 22: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – Artificial Insemination, 2015–2025
Table 23: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure 2015–2025
Table 24: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 25: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 26: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 27: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – In Vitro Fertilization, 2015–2025
Table 28: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – Artificial Insemination, 2015–2025
Table 29: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure 2015–2025
Table 30: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 31: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 32: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 33: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – In Vitro Fertilization, 2015–2025
Table 34: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology – Artificial Insemination, 2015–2025
Table 35: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure 2015–2025
Table 36: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025

Global Assisted Reproductive Technology Market: Overview

The report on the assisted reproductive technology market analyzes the current and future scenario of the global market. Increase in prevalence of infertility, advent of new technology for development of new devices for ARdT procedure for high success rate, and increase in adoption and awareness for IVF and surrogacy, are the major drivers of the global assisted reproductive technology market.

The assisted reproductive technology market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global assisted reproductive technology market with respect to the segments based on technology, procedures, end users and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters five forces analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global assisted reproductive technology market.

Global Assisted Reproductive Technology Market: Segmentation

Based on technology type, the assisted reproductive technology market is segmented as in vitro fertilization, artificial insemination, surrogacy and others. The in vitro fertilization is further segmented into intra-cytoplasmic sperm injection (ICSI), and preimplantation genetic diagnosis (PGD). The artificial insemination is segmented into intrauterine insemination (IUI), and intracervical insemination (ICI) and others. The technology market segments have been analyzed based on available approved technology and devices, cost-effectiveness, and preference for technology and procedures by physicians and embryologists. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on procedures, assisted reproductive technology market is segmented into frozen donor, frozen non donor, fresh donor, fresh non donor, and embryo banking. Based on end user, assisted reproductive technology market is segmented into fertility clinics, hospitals and others. The market segments have been extensively analyzed based on demand for technology and procedure, success rate of procedure and available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Assisted Reproductive Technology Market: Geographical and Competitive Dynamics

Geographically, the global assisted reproductive technology market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global assisted reproductive technology market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Merck KGaA, CooperSurgical, Inc., Irvine Scientific, Vitrolife AB, Hamilton Thorne, Inc., Nidacon International AB, Laboratoire CCD, Planer PLC, Esco Micro Pte. Ltd. (Esco Group), Nikon Corporation and others

The Global Assisted Reproductive Technology Market is segmented as given below:

Global Assisted Reproductive Technology Market, by Technology

  • In Vitro Fertilization
    • Intra-cytoplasmic Sperm Injection (ICSI)
    • Preimplantation Genetic Diagnosis (PGD)
  • Artificial Insemination
    • Intrauterine Insemination (IUI)
    • Intracervical Insemination (ICI)
    • Others
  • Surrogacy
  • Others

Global Assisted Reproductive Technology Market, by Procedure

  • Frozen Donor
  • Frozen Non Donor
  • Fresh Donor
  • Fresh Non Donor
  • Embryo Banking

Global Assisted Reproductive Technology Market, by End User

  • Fertility Clinics
  • Hospitals
  • Others

Global Assisted Reproductive Technology Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Russia
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top